Infinity Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Matt Bannon and Tessa Romero from the team.
Our next presenting company is Infinity. And speaking on behalf of the company, we have CEO, Adelene Perkins. (Operator Instructions)
With that, I'll pass it over to you, Adelene.
Thank you, Anupam, and we can start with the slides. Thank you very much to JPMorgan for inviting Infinity Pharmaceuticals to present again this year and for all of you for listening to today's presentation.
It's a very important time at the company as we complete a data-rich 2020 and expect a data-rich 2021, starting with new data next month. There is a compelling investment thesis based on 4 data presentations over the past 2 months with eganelisib, our first-in-class immuno-oncology therapeutic with which
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
